The Industry’s Dirty Secret: The Data Are Inaccurate
Patient satisfaction may be increasingly important in healthcare, but the industry hasn’t made the appropriate changes yet, 2 employees from Prime Therapeutics said in back-to-back sessions at the 64th Annual Roy A. Bowers Pharmaceutical Conference.
Supreme Court Passes on ACA Subsidy Case—For Now
At this time, the Supreme Court of the United States has declined to hear an appeal of one of the cases challenging the legality of making subsidies under the Affordable Care Act available to consumers on the federally run health insurance exchanges.
Limited Literacy, Numeracy Hurts Those the ACA Is Meant to Help
The Affordable Care Act expanded healthcare coverage to many low-income Americans, but this same demographic has a low health literacy that makes it difficult for them to navigate program eligibility systems, according to a study from The Urban Institute.
Kindred Healthcare Names New CEO
Kindred Healthcare, Inc’s chief operating officer and president, Benjamin A. Breier will take over as chief executive officer next year, just after the company is expected to close its acquisition of Gentiva Health Services.
Healthcare Transformation and the Price of Pharmaceuticals
Panelists discussed the price of pharmaceuticals and controlling the cost of care at the 64th Annual Roy A. Bowers Pharmaceutical Conference: A Measured Approach—Health Care Delivery and Transformation in a Metric Driven World, held by Rutgers University.
Dr Karen B. DeSalvo Not Leaving ONC Just Yet
The Office of the National Coordinator for Health Information Technology (ONC) seemed to be in dire straits as its leadership slowly left for other jobs. However, despite Dr DeSalvo’s new position within HHS, she will maintain her leadership position in ONC, according to a new report.
Prostate Cancer Screening Remains Highly Debated
While the USPSTF recommended against screening for prostate cancer, citing the high rate of false positives, complications from biopsy, and side-effects of aggressive treatment for a sometimes slowly-progressing disease, several medical organizations disagree.